Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

NCT02381314

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • UCLA Hematology-Oncology Clinic Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Safety Study of MGA271 in Refractory Cancer

NCT01391143

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +49 more
Locations
  • UCLA Hematology-Oncology Clinic Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy

NCT03278665

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Universitätsklinikum Essen Essen, Germany
  • Medizinische Hochschule Hannover Hanover, Germany
  • Universitätsklinikum Heidelberg Heidelberg, Germany
  • Klinikum der Universität München München, Germany
View Trial Details
Completed

Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma

NCT02083354

Conditions
Cancer, Melanoma, Neoplasms, +10 more
Locations
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Kunming, Yunnan, China
  • Novartis Investigative Site Hangzhou, Zhejiang, China
  • Novartis Investigative Site Beijing, China
View all 13 locations
View Trial Details
Completed

A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma

NCT01511913

Conditions
Advanced Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Local Institution Gilbert, Arizona, United States
  • Local Institution Hot Springs, Arkansas, United States
  • Local Institution Encinitas, California, United States
  • Local Institution La Jolla, California, United States
View all 186 locations
View Trial Details
Completed

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

NCT01772004

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Cortex Diseases, +62 more
Locations
  • Cancer Treatment Centers of America - Western Regional Medical Center Goodyear, Arizona, United States
  • Scottsdale Healthcare Corporation Scottsdale, Arizona, United States
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
View all 74 locations
View Trial Details
Completed

A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors

NCT02573259

Conditions
Carcinoma, Carcinoma, Transitional Cell, Melanoma, +21 more
Locations
  • Clinical Research Unit Los Angeles, California, United States
  • Ronald Reagan Medical Center, Department of Radiological Sciences Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
View all 67 locations
View Trial Details

Related conditions